HK1198587A1 - Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2- - Google Patents
Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2-Info
- Publication number
- HK1198587A1 HK1198587A1 HK14112083A HK14112083A HK1198587A1 HK 1198587 A1 HK1198587 A1 HK 1198587A1 HK 14112083 A HK14112083 A HK 14112083A HK 14112083 A HK14112083 A HK 14112083A HK 1198587 A1 HK1198587 A1 HK 1198587A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- isothiazolopyridine
- carboxamides
- pharmaceuticals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306711 | 2011-12-20 | ||
| PCT/EP2012/075932 WO2013092574A1 (en) | 2011-12-20 | 2012-12-18 | Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1198587A1 true HK1198587A1 (en) | 2015-04-30 |
Family
ID=47429823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14112083A HK1198587A1 (en) | 2011-12-20 | 2014-12-01 | Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2- |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9260454B2 (hu) |
| EP (1) | EP2794618B1 (hu) |
| JP (1) | JP6099669B2 (hu) |
| KR (1) | KR20140103150A (hu) |
| CN (1) | CN104136443B (hu) |
| AR (1) | AR089329A1 (hu) |
| AU (1) | AU2012357864B2 (hu) |
| BR (1) | BR112014015033A2 (hu) |
| CA (1) | CA2856964A1 (hu) |
| CY (1) | CY1118854T1 (hu) |
| DK (1) | DK2794618T3 (hu) |
| ES (1) | ES2613826T3 (hu) |
| HK (1) | HK1198587A1 (hu) |
| HR (1) | HRP20170159T1 (hu) |
| HU (1) | HUE033049T2 (hu) |
| IL (1) | IL232809A (hu) |
| LT (1) | LT2794618T (hu) |
| MX (1) | MX2014007465A (hu) |
| PL (1) | PL2794618T3 (hu) |
| PT (1) | PT2794618T (hu) |
| RU (1) | RU2014129903A (hu) |
| SG (1) | SG11201402623RA (hu) |
| SI (1) | SI2794618T1 (hu) |
| WO (1) | WO2013092574A1 (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6814730B2 (ja) * | 2014-09-05 | 2021-01-20 | ジェネンテック， インコーポレイテッド | 治療用化合物およびその使用 |
| WO2017030892A1 (en) * | 2015-08-14 | 2017-02-23 | Reaction Biology Corp. | Histone deacetylase inhibitors and methods for use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3892745A (en) * | 1972-11-20 | 1975-07-01 | Sankyo Co | Isoxazolone derivatives and process for preparing the same |
| US3965107A (en) | 1974-07-08 | 1976-06-22 | Rohm And Haas Company | Isothiazolopyridinones |
| LU84091A1 (fr) * | 1982-04-16 | 1984-03-02 | Oreal | Derives n-carbamoyl d'isothiazolo-(5,4b)pyridine one-3,leur procede de preparation et leurs utilisations comme agents bactericides et fongicides |
| US4968713A (en) | 1989-07-31 | 1990-11-06 | Merck & Co., Inc. | Certain imidazole compounds as transglutaminase inhibitors |
| DE10054687A1 (de) | 2000-11-03 | 2002-05-16 | N Zyme Biotec Gmbh | Inhibitoren von Transglutaminasen |
| US7595403B2 (en) * | 2003-04-01 | 2009-09-29 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
| WO2004094393A1 (en) * | 2003-04-01 | 2004-11-04 | Eli Lilly And Company | Phospholipase inhibitors |
| GB0314262D0 (en) | 2003-06-19 | 2003-07-23 | Univ Nottingham Trent | Novel compounds and methods of using the same |
| US20070197610A1 (en) * | 2004-03-16 | 2007-08-23 | Janssen Pharmaceutica N.V. | Benzisoxazoles |
| DE102006014688A1 (de) * | 2006-03-28 | 2007-10-04 | Sanofi-Aventis | Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
| DE102006052755A1 (de) | 2006-11-08 | 2008-05-15 | N-Zyme Biotec Gmbh | Michaelsysteme als Transglutaminaseinhibitoren |
| WO2011060321A1 (en) | 2009-11-16 | 2011-05-19 | Chdi, Inc. | Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof |
| US8933024B2 (en) * | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
-
2012
- 2012-12-18 PT PT128060431T patent/PT2794618T/pt unknown
- 2012-12-18 WO PCT/EP2012/075932 patent/WO2013092574A1/en active Application Filing
- 2012-12-18 ES ES12806043.1T patent/ES2613826T3/es active Active
- 2012-12-18 SI SI201230855A patent/SI2794618T1/sl unknown
- 2012-12-18 CA CA2856964A patent/CA2856964A1/en not_active Abandoned
- 2012-12-18 MX MX2014007465A patent/MX2014007465A/es unknown
- 2012-12-18 AU AU2012357864A patent/AU2012357864B2/en not_active Ceased
- 2012-12-18 KR KR1020147019341A patent/KR20140103150A/ko not_active Application Discontinuation
- 2012-12-18 PL PL12806043T patent/PL2794618T3/pl unknown
- 2012-12-18 LT LTEP12806043.1T patent/LT2794618T/lt unknown
- 2012-12-18 JP JP2014547921A patent/JP6099669B2/ja not_active Expired - Fee Related
- 2012-12-18 DK DK12806043.1T patent/DK2794618T3/en active
- 2012-12-18 EP EP12806043.1A patent/EP2794618B1/en active Active
- 2012-12-18 CN CN201280070206.0A patent/CN104136443B/zh not_active Expired - Fee Related
- 2012-12-18 RU RU2014129903A patent/RU2014129903A/ru not_active Application Discontinuation
- 2012-12-18 BR BR112014015033A patent/BR112014015033A2/pt not_active IP Right Cessation
- 2012-12-18 SG SG11201402623RA patent/SG11201402623RA/en unknown
- 2012-12-18 HU HUE12806043A patent/HUE033049T2/hu unknown
- 2012-12-19 AR ARP120104822A patent/AR089329A1/es unknown
-
2014
- 2014-05-26 IL IL232809A patent/IL232809A/en not_active IP Right Cessation
- 2014-06-18 US US14/307,961 patent/US9260454B2/en active Active
- 2014-12-01 HK HK14112083A patent/HK1198587A1/xx not_active IP Right Cessation
-
2017
- 2017-02-01 HR HRP20170159TT patent/HRP20170159T1/hr unknown
- 2017-02-15 CY CY20171100208T patent/CY1118854T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014015033A2 (pt) | 2017-06-13 |
| ES2613826T3 (es) | 2017-05-26 |
| AU2012357864A1 (en) | 2014-07-03 |
| US20140296169A1 (en) | 2014-10-02 |
| CN104136443A (zh) | 2014-11-05 |
| WO2013092574A1 (en) | 2013-06-27 |
| IL232809A0 (en) | 2014-08-03 |
| AR089329A1 (es) | 2014-08-13 |
| DK2794618T3 (en) | 2017-02-20 |
| CA2856964A1 (en) | 2013-06-27 |
| CN104136443B (zh) | 2017-01-18 |
| JP2015500855A (ja) | 2015-01-08 |
| MX2014007465A (es) | 2014-07-30 |
| HUE033049T2 (hu) | 2017-11-28 |
| AU2012357864B2 (en) | 2017-03-02 |
| KR20140103150A (ko) | 2014-08-25 |
| LT2794618T (lt) | 2017-02-27 |
| JP6099669B2 (ja) | 2017-03-22 |
| SI2794618T1 (sl) | 2017-03-31 |
| EP2794618B1 (en) | 2016-11-16 |
| SG11201402623RA (en) | 2014-09-26 |
| EP2794618A1 (en) | 2014-10-29 |
| US9260454B2 (en) | 2016-02-16 |
| HRP20170159T1 (hr) | 2017-03-24 |
| IL232809A (en) | 2017-05-29 |
| CY1118854T1 (el) | 2018-01-10 |
| PT2794618T (pt) | 2017-01-17 |
| RU2014129903A (ru) | 2016-02-10 |
| PL2794618T3 (pl) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100012I1 (hu) | 4-Imidazopiridazin-1-il-benzamidok és 4-imidazotriazin-1-il-benzamidok mint BTK-gátlók | |
| IL233051A0 (en) | Anti-phf-tau antibodies and uses thereof | |
| HK1198433A1 (en) | N-acyldipeptide derivatives and their uses n- | |
| IL229844B (en) | Anti-psgl-1 antibodies and their use | |
| GB201111705D0 (en) | Compounds and their use | |
| HK1191034A1 (en) | N-carboxyalkyl-auristatins and use thereof n- | |
| GB201110783D0 (en) | Methods and uses | |
| IL231082A0 (en) | Pyrimido-pyridazinone compounds and their use | |
| EP2688588A4 (en) | FAST AND LONG-TERM IMMUNOLOGICAL THERAPEUTIC | |
| GB201111630D0 (en) | Novel compounds and their use | |
| GB201116774D0 (en) | Uses and methods | |
| EP2697386A4 (en) | DESIGN AND USE OF PEPDUCINE | |
| EP2716359A4 (en) | COMPLEX AND USES THEREOF | |
| GB201111775D0 (en) | Compounds and uses thereof | |
| GB201114448D0 (en) | Compounds and their use | |
| EP2668044A4 (en) | COMPOSITIONS AND THEIR USE | |
| GB201106357D0 (en) | Composition and uses thereof | |
| EP2693879A4 (en) | MIGRASTATINES AND THEIR USES | |
| HK1198587A1 (en) | Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2- | |
| GB201108490D0 (en) | Methods and uses | |
| PT2734522T (pt) | 4-imidazopiridazina-1-il-benzamidas e 4-imidazotriazin-1- il-benzamidas como inibidores de btk | |
| GB201104444D0 (en) | Compounds and their use | |
| GB201121551D0 (en) | Compounds and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20201220 |